Pregnane X receptor (PXR) is a member of the nuclear receptor (NR) superfamily of ligand-activated transcription factors and is activated by a huge variety of endobiotics and xenobiotics, including many clinical drugs. PXR plays key roles not only as a xenosensor in the regulation of both major phase I and II drug metabolism and transporters but also as a physiological sensor in the modulation of bile acid and cholesterol metabolism, glucose and lipid metabolism, and bone and endocrine homeostasis. Post-translational modifications such as phosphorylation have been shown to modulate the activity of many NRs, including PXR, and constitute an important mechanism for crosstalk between signaling pathways and regulation of genes involved in both xenobiotic and endobiotic metabolism. In addition, microRNAs have recently been shown to constitute another level of PXR activity regulation. The objective of this review is to comprehensively summarize current understanding of post-transcriptional and post-translational modifications of PXR in regulation of xenobiotic-metabolizing cytochrome P450 (CYP) genes, mainly in hepatic tissue. We also discuss the importance of PXR in crosstalk with cell signaling pathways, which at the level of transcription modify expression of genes associated with some physiological and pathological stages in the organs. Finally, we indicate that these PXR modifications may have important impacts on CYP-mediated biotransformation of some clinically used drugs.

Faculty of Pharmacy in Hradec Králové Charles University Prague Heyrovského 1203 Hradec Králové 500 05 Czech Republic European Union

Zobrazit více v PubMed

Ema M, Matsushita N, Sogawa K, Ariyama T, Inazawa J, Nemoto T, Ota M, Oshimura M, Fujii-Kuriyama Y. Human arylhydrocarbon receptor: Functional expression and chromosomal assignment to 7p21. J Biochem. 1994;116(4):845–851. PubMed

Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD. A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements. Mol Cell Biol. 1994;14(3):1544–1552. PubMed PMC

Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, McKee DD, Oliver BB, Willson TM, Zetterstrom RH, Perlmann T, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 1998;92(1):73–82. PubMed

Bertilsson G, Heidrich J, Svensson K, Asman M, Jendeberg L, Sydow-Backman M, Ohlsson R, Postlind H, Blomquist P, Berkenstam A. Identification of a human nuclear receptor defines a new signaling pathway for cyp3a induction. Proc Natl Acad Sci U S A. 1998;95(21):12208–12213. PubMed PMC

Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor pxr is activated by compounds that regulate cyp3a4 gene expression and cause drug interactions. J Clin Invest. 1998;102(5):1016–1023. PubMed PMC

Blumberg B, Sabbagh W, Jr, Juguilon H, Bolado J, Jr, van Meter CM, Ong ES, Evans RM. Sxr, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 1998;12(20):3195–3205. PubMed PMC

Wada T, Gao J, Xie W. Pxr and car in energy metabolism. Trends Endocrinol Metab. 2009;20(6):273–279. PubMed

Ma X, Idle JR, Gonzalez FJ. The pregnane x receptor: From bench to bedside. Expert Opin Drug Metab Toxicol. 2008;4(7):895–908. PubMed PMC

Wang YM, Ong SS, Chai SC, Chen T. Role of car and pxr in xeno-biotic sensing and metabolism. Expert Opin Drug Metab Toxicol. 2012;8(7):803–817. PubMed PMC

Nishimura M, Naito S, Yokoi T. Tissue-specific mrna expression profiles of human nuclear receptor subfamilies. Drug Metab Pharmacokinet. 2004;19(2):135–149. PubMed

Pavek P, Dvorak Z. Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome p450 superfamily in human extrahepatic tissues. Curr Drug Metab. 2008;9(2):129–143. PubMed

Zhou C, Verma S, Blumberg B. The steroid and xenobiotic receptor (sxr), beyond xenobiotic metabolism. Nucl Recept Signal. 2009;7:e001. PubMed PMC

di Masi A, De Marinis E, Ascenzi P, Marino M. Nuclear receptors car and pxr: Molecular, functional, and biomedical aspects. Mol Aspects Med. 2009;30(5):297–343. PubMed

Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR. The human nuclear xenobiotic receptor pxr: Structural determinants of directed promiscuity. Science. 2001;292(5525):2329–2333. PubMed

Ekins S, Chang C, Mani S, Krasowski MD, Reschly EJ, Iyer M, Kholodovych V, Ai N, Welsh WJ, Sinz M, Swaan PW, et al. Human pregnane x receptor antagonists and agonists define molecular requirements for different binding sites. Mol Pharmacol. 2007;72(3):592–603. PubMed

Cai Y, Konishi T, Han G, Campwala KH, French SW, Wan YJ. The role of hepatocyte rxr alpha in xenobiotic-sensing nuclear receptor-mediated pathways. Eur J Pharm Sci. 2002;15(1):89–96. PubMed

Rosenfeld MG, Lunyak VV, Glass CK. Sensors and signals: A coactivator/corepressor/epigenetic code for integrating signal-dependent programs of transcriptional response. Genes Dev. 2006;20(11):1405–1428. PubMed

Synold TW, Dussault I, Forman BM. The orphan nuclear receptor sxr coordinately regulates drug metabolism and efflux. Nat Med. 2001;7(5):584–590. PubMed

Takeshita A, Taguchi M, Koibuchi N, Ozawa Y. Putative role of the orphan nuclear receptor sxr (steroid and xenobiotic receptor) in the mechanism of cyp3a4 inhibition by xenobiotics. J Biol Chem. 2002;277(36):32453–32458. PubMed

Ourlin JC, Lasserre F, Pineau T, Fabre JM, Sa-Cunha A, Maurel P, Vilarem MJ, Pascussi JM. The small heterodimer partner interacts with the pregnane x receptor and represses its transcriptional activity. Mol Endocrinol. 2003;17(9):1693–1703. PubMed

Goodwin B, Moore LB, Stoltz CM, McKee DD, Kliewer SA. Regulation of the human cyp2b6 gene by the nuclear pregnane x receptor. Mol Pharmacol. 2001;60(3):427–431. PubMed

Gerbal-Chaloin S, Pascussi JM, Pichard-Garcia L, Daujat M, Waechter F, Fabre JM, Carrere N, Maurel P. Induction of cyp2c genes in human hepatocytes in primary culture. Drug Metab Dispos. 2001;29(3):242–251. PubMed

Staudinger JL, Ding X, Lichti K. Pregnane x receptor and natural products: Beyond drug-drug interactions. Expert Opin Drug Metab Toxicol. 2006;2(6):847–857. PubMed PMC

Sinz M, Kim S, Zhu Z, Chen T, Anthony M, Dickinson K, Rodrigues AD. Evaluation of 170 xenobiotics as transactivators of human pregnane x receptor (hpxr) and correlation to known cyp3a4 drug interactions. Curr Drug Metab. 2006;7(4):375–388. PubMed

Li AP, Kaminski DL, Rasmussen A. Substrates of human hepatic cytochrome p450 3a4. Toxicology. 1995;104(1–3):1–8. PubMed

Martinez-Jimenez CP, Jover R, Donato MT, Castell JV, Gomez-Lechon MJ. Transcriptional regulation and expression of cyp3a4 in hepatocytes. Curr Drug Metab. 2007;8(2):185–194. PubMed

Plant N. Use of reporter genes to measure xenobiotic-mediated activation of cyp gene transcription. Methods Mol Biol. 2006;320:343–354. PubMed

Lin JH. Cyp induction-mediated drug interactions: In vitro assessment and clinical implications. Pharm Res. 2006;23(6):1089–1116. PubMed

Staudinger JL, Xu C, Biswas A, Mani S. Post-translational modification of pregnane x receptor. Pharmacol Res. 2011 PubMed PMC

Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W, Tian Y. Role of nf-kappab in regulation of pxr-mediated gene expression: A mechanism for the suppression of cytochrome p-450 3a4 by proinflammatory agents. J Biol Chem. 2006;281(26):17882–17889. PubMed

Zhou C, Tabb MM, Nelson EL, Grun F, Verma S, Sadatrafiei A, Lin M, Mallick S, Forman BM, Thummel KE, Blumberg B. Mutual repression between steroid and xenobiotic receptor and nf-kappab signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest. 2006;116(8):2280–2289. PubMed PMC

Shah YM, Ma X, Morimura K, Kim I, Gonzalez FJ. Pregnane x receptor activation ameliorates dss-induced inflammatory bowel disease via inhibition of nf-kappab target gene expression. Am J Physiol Gastrointest Liver Physiol. 2007;292(4):G1114–1122. PubMed

Kodama S, Koike C, Negishi M, Yamamoto Y. Nuclear receptors car and pxr cross talk with foxo1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes. Mol Cell Biol. 2004;24(18):7931–7940. PubMed PMC

Bhalla S, Ozalp C, Fang S, Xiang L, Kemper JK. Ligand-activated pregnane x receptor interferes with hnf-4 signaling by targeting a common coactivator pgc-1alpha. Functional implications in hepatic cholesterol and glucose metabolism. J Biol Chem. 2004;279(43):45139–45147. PubMed

Igarashi M, Yogiashi Y, Mihara M, Takada I, Kitagawa H, Kato S. Vitamin k induces osteoblast differentiation through pregnane x receptor-mediated transcriptional control of the msx2 gene. Mol Cell Biol. 2007;27(22):7947–7954. PubMed PMC

Zhai Y, Pai HV, Zhou J, Amico JA, Vollmer RR, Xie W. Activation of pregnane x receptor disrupts glucocorticoid and mineralo-corticoid homeostasis. Mol Endocrinol. 2007;21(1):138–147. PubMed

Biswas A, Pasquel D, Tyagi RK, Mani S. Acetylation of pregnane x receptor protein determines selective function independent of ligand activation. Biochem Biophys Res Commun. 2011;406(3):371–376. PubMed PMC

Ding X, Staudinger JL. Repression of pxr-mediated induction of hepatic cyp3a gene expression by protein kinase c. Biochem Pharmacol. 2005;69(5):867–873. PubMed

Lin W, Wu J, Dong H, Bouck D, Zeng FY, Chen T. Cyclin-dependent kinase 2 negatively regulates human pregnane x receptor-mediated cyp3a4 gene expression in hepg2 liver carcinoma cells. J Biol Chem. 2008;283(45):30650–30657. PubMed PMC

Sugatani J, Osabe M, Kurosawa M, Kitamura N, Ikari A, Miwa M. Induction of ugt1a1 and cyp2b6 by an antimitogenic factor in hepg2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: Cell cycle-dependent expression. Drug Metab Dispos. 2010;38(1):177–186. PubMed

Dong H, Lin W, Wu J, Chen T. Flavonoids activate pregnane x receptor-mediated cyp3a4 gene expression by inhibiting cyclin-dependent kinases in hepg2 liver carcinoma cells. BMC Biochem. 2010;11(23) PubMed PMC

Pondugula SR, Brimer-Cline C, Wu J, Schuetz EG, Tyagi RK, Chen T. A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor. Drug Metab Dispos. 2009;37(4):719–730. PubMed PMC

Ding X, Staudinger JL. Induction of drug metabolism by forskolin: The role of the pregnane x receptor and the protein kinase a signal transduction pathway. J Pharmacol Exp Ther. 2005;312(2):849–856. PubMed

Lichti-Kaiser K, Xu C, Staudinger JL. Cyclic amp-dependent protein kinase signaling modulates pregnane x receptor activity in a species-specific manner. J Biol Chem. 2009;284(11):6639–6649. PubMed PMC

Lichti-Kaiser K, Brobst D, Xu C, Staudinger JL. A systematic analysis of predicted phosphorylation sites within the human pregnane x receptor protein. J Pharmacol Exp Ther. 2009;331(1):65–76. PubMed PMC

Ueda A, Matsui K, Yamamoto Y, Pedersen LC, Sueyoshi T, Negishi M. Thr176 regulates the activity of the mouse nuclear receptor car and is conserved in the nr1i subfamily members pxr and vdr. Biochem J. 2005;388(Pt 2):623–630. PubMed PMC

Doricakova A, Novotna A, Vrzal R, Pavek P, Dvorak Z. The role of residues t248, y249 and t422 in the function of human pregnane x receptor. Arch Toxicol. 2013;87(2):291–301. PubMed

Hu G, Xu C, Staudinger JL. Pregnane x receptor is sumoylated to repress the inflammatory response. J Pharmacol Exp Ther. 2010;335(2):342–350. PubMed PMC

Rana R, Coulter S, Kinyamu H, Goldstein JA. Rbck1, an e3 ubiquitin ligase, interacts with and ubiquinates the human pregnane x receptor. Drug Metab Dispos. 2012;41(2):398–405. PubMed PMC

Rochette-Egly C. Nuclear receptors: Integration of multiple signalling pathways through phosphorylation. Cell Signal. 2003;15(4):355–366. PubMed

Pondugula SR, Dong H, Chen T. Phosphorylation and protein-protein interactions in pxr-mediated cyp3a repression. Expert Opin Drug Metab Toxicol. 2009;5(8):861–873. PubMed PMC

Sugatani J, Uchida T, Kurosawa M, Yamaguchi M, Yamazaki Y, Ikari A, Miwa M. Regulation of pregnane x receptor (pxr) function and ugt1a1 gene expression by posttranslational modification of pxr protein. Drug Metab Dispos. 2012;40(10):2031–2040. PubMed

Morgan ET, Goralski KB, Piquette-Miller M, Renton KW, Robertson GR, Chaluvadi MR, Charles KA, Clarke SJ, Kacevska M, Liddle C, Richardson TA, et al. Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer. Drug Metab Dispos. 2008;36(2):205–216. PubMed

Kim SK, Novak RF. The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression. Pharmacol Ther. 2007;113(1):88–120. PubMed PMC

Sayeed MM. Alterations in cell signaling and related effector functions in t lymphocytes in burn/trauma/septic injuries. Shock. 1996;5(3):157–166. PubMed

Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, Beaune P, Guillouzo A. Cytokines down-regulate expression of major cytochrome p-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol. 1993;44(4):707–715. PubMed

Muntane-Relat J, Ourlin JC, Domergue J, Maurel P. Differential effects of cytokines on the inducible expression of cyp1a1, cyp1a2, and cyp3a4 in human hepatocytes in primary culture. Hepatology. 1995;22(4 Pt 1):1143–1153. PubMed

Jover R, Bort R, Gomez-Lechon MJ, Castell JV. Down-regulation of human cyp3a4 by the inflammatory signal interleukin-6: Molecular mechanism and transcription factors involved. Faseb J. 2002;16(13):1799–1801. PubMed

Hines RN. Ontogeny of human hepatic cytochromes p450. J Biochem Mol Toxicol. 2007;21(4):169–175. PubMed

Donato MT, Gomez-Lechon MJ, Jover R, Nakamura T, Castell JV. Human hepatocyte growth factor down-regulates the expression of cytochrome p450 isozymes in human hepatocytes in primary culture. J Pharmacol Exp Ther. 1998;284(2):760–767. PubMed

Gomez-Lechon MJ, Castelli J, Guillen I, O’Connor E, Nakamura T, Fabra R, Trullenque R. Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture. Hepatology. 1995;21(5):1248–1254. PubMed

Greuet J, Pichard L, Ourlin JC, Bonfils C, Domergue J, Le Treut P, Maurel P. Effect of cell density and epidermal growth factor on the inducible expression of cyp3a and cyp1a genes in human hepatocytes in primary culture. Hepatology. 1997;25(5):1166–1175. PubMed

Braeuning A. Regulation of cytochrome p450 expression by ras- and beta-catenin-dependent signaling. Curr Drug Metab. 2009;10(2):138–158. PubMed

Shima N, Stolz DB, Miyazaki M, Gohda E, Higashio K, Michalopoulos GK. Possible involvement of p21/waf1 in the growth inhibition of hepg2 cells induced by hepatocyte growth factor. J Cell Physiol. 1998;177(1):130–136. PubMed

Sivertsson L, Edebert I, Palmertz MP, Ingelman-Sundberg M, Neve EP. Induced cyp3a4 expression in confluent huh7 hepatoma cells as a result of decreased cell proliferation and subsequent pregnane x receptor activation. Mol Pharmacol. 2013;83(3):659–670. PubMed

Zhu J, Li W, Mao Z. Cdk5: Mediator of neuronal development, death and the response to DNA damage. Mech Ageing Dev. 2011;132(8–9):389–394. PubMed PMC

Min L, He B, Hui L. Mitogen-activated protein kinases in hepatocellular carcinoma development. Semin Cancer Biol. 2010;21(1):10–20. PubMed

Zassadowski F, Rochette-Egly C, Chomienne C, Cassinat B. Regulation of the transcriptional activity of nuclear receptors by the mek/erk1/2 pathway. Cell Signal. 2012;24(12):2369–2377. PubMed

Elias A, High AA, Mishra A, Ong SS, Wu J, Peng J, Chen T. Identification and characterization of phosphorylation sites within the pregnane x receptor protein. Biochem Pharmacol. 2013 PubMed PMC

Portbury AL, Ronnebaum SM, Zungu M, Patterson C, Willis MS. Back to your heart: Ubiquitin proteasome system-regulated signal transduction. J Mol Cell Cardiol. 2012;52(3):526–537. PubMed PMC

Masuyama H, Hiramatsu Y, Kunitomi M, Kudo T, MacDonald PN. Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate pregnane x receptor-mediated transcription. Mol Endocrinol. 2000;14(3):421–428. PubMed

Rubin DM, Coux O, Wefes I, Hengartner C, Young RA, Goldberg AL, Finley D. Identification of the gal4 suppressor sug1 as a subunit of the yeast 26s proteasome. Nature. 1996;379(6566):655–657. PubMed

Bossis G, Melchior F. Sumo: Regulating the regulator. Cell Div. 2006;1(13) PubMed PMC

Masuyama H, Inoshita H, Hiramatsu Y, Kudo T. Ligands have various potential effects on the degradation of pregnane x receptor by proteasome. Endocrinology. 2002;143(1):55–61. PubMed

Treuter E, Venteclef N. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor sumoylation. Biochim Biophys Acta. 2010;1812(8):909–918. PubMed

Wang C, Tian L, Popov VM, Pestell RG. Acetylation and nuclear receptor action. J Steroid Biochem Mol Biol. 2011;123(3–5):91–100. PubMed PMC

Buler M, Aatsinki SM, Skoumal R, Hakkola J. Energy sensing factors pgc-1alpha and sirt1 modulate pxr expression and function. Biochem Pharmacol. 2011;82(12):2008–2015. PubMed

Nakajima M, Yokoi T. Micrornas from biology to future pharmacotherapy: Regulation of cytochrome p450s and nuclear receptors. Pharmacol Ther. 2011;131(3):330–337. PubMed

Takagi S, Nakajima M, Mohri T, Yokoi T. Post-transcriptional regulation of human pregnane x receptor by micro-rna affects the expression of cytochrome p450 3a4. J Biol Chem. 2008;283(15):9674–9680. PubMed

Wei Z, Chen M, Zhang Y, Wang X, Jiang S, Wang Y, Wu X, Qin S, He L, Zhang L, Xing Q. No correlation of hsa-mir-148a with expression of pxr or cyp3a4 in human livers from chinese han population. PLoS One. 2013;8(3):e59141. PubMed PMC

Rieger JK, Klein K, Winter S, Zanger UM. Expression variability of adme-related micrornas in human liver: Influence of non-genetic factors and association with gene expression. Drug Metab Dispos. 2013 doi: 10.1124/dmd.113.052126. PubMed DOI

Staudinger JL, Lichti K. Cell signaling and nuclear receptors: New opportunities for molecular pharmaceuticals in liver disease. Mol Pharm. 2008;5(1):17–34. PubMed PMC

Allosteric Antagonism of the Pregnane X Receptor (PXR): Current-State-of-the-Art and Prediction of Novel Allosteric Sites

Rifampicin Induces Gene, Protein, and Activity of P-Glycoprotein (ABCB1) in Human Precision-Cut Intestinal Slices

Transcriptional and post-transcriptional regulation of the pregnane X receptor: a rationale for interindividual variability in drug metabolism

Targeting the pregnane X receptor using microbial metabolite mimicry

The 3'-untranslated region contributes to the pregnane X receptor (PXR) expression down-regulation by PXR ligands and up-regulation by glucocorticoids

Mathematical Models in the Description of Pregnane X Receptor (PXR)-Regulated Cytochrome P450 Enzyme Induction

Pregnane X Receptor (PXR)-Mediated Gene Repression and Cross-Talk of PXR with Other Nuclear Receptors via Coactivator Interactions

Acetylation of lysine 109 modulates pregnane X receptor DNA binding and transcriptional activity

Pregnane X Receptor and Cancer: Context-Specificity is Key